NFKB1 and metabolic dysfunction-associated steatotic liver disease: Activation of NF-kB by the tumor necrosis factor receptor (TNF-R) and the NOD-like receptor family pyrin domain-containing 3 (NLRP3) is well and reported in NAFLD/NASH models.